| RS796053460 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Ovarian cancer |
| RS796053461 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS796053462 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS796053464 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS796053466 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS796053470 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS796053471 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS796053473 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053474 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS796053475 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053476 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053479 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053480 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS796053482 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053483 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, Tuberous sclerosis 2 |
| RS796053484 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS796053485 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS796053486 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053487 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS796053488 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053491 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053492 |
TSC2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS796053493 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053495 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053496 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS796053498 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053499 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053503 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053504 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053505 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053506 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053507 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053509 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS796053511 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053512 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053513 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS796053514 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, TSC2-related disorder |
| RS796053515 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053516 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS796053517 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053518 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053519 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS796053520 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS796053521 |
RFT1
|
Health Risk |
Pathogenic |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS796053522 |
RFT1
|
Health Risk |
Pathogenic |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS79606317 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS796064501 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS796064502 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS796064503 |
PAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS796064508 |
CBLIF
|
Health Risk |
Pathogenic |
Hereditary intrinsic factor deficiency, Hereditary intrinsic factor deficiency |
| RS796064510 |
MTHFD1
|
Health Risk |
Pathogenic |
Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia |
| RS796064513 |
MMACHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cobalamin C disease, MMACHC-related disorder |
| RS796065022 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 3A |
| RS796065023 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 3A |
| RS796065024 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS796065025 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS796065026 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS796065027 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS796065028 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS796065029 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS796065030 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS796065031 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS796065032 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS796065033 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS796065034 |
POMC
|
Health Risk |
Pathogenic |
Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS796065035 |
POMC
|
Health Risk |
Pathogenic |
Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS796065036 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS796065037 |
NBAS
|
Health Risk |
Pathogenic |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS796065038 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 2, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS796065040 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS796065041 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS796065042 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS796065043 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS796065044 |
SLC34A2
|
Health Risk |
Pathogenic |
PULMONARY ALVEOLAR MICROLITHIASIS, PULMONARY ALVEOLAR MICROLITHIASIS |
| RS796065045 |
NOTCH3
|
Health Risk |
Pathogenic |
Lateral meningocele syndrome, Lateral meningocele syndrome |
| RS796065046 |
ALDH6A1
|
Health Risk |
Pathogenic |
Methylmalonate semialdehyde dehydrogenase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency |
| RS796065051 |
BRD7
|
Health Risk |
Likely pathogenic |
Granular cell cancer, Granular cell cancer |
| RS796065052 |
STAT1
|
Health Risk |
Likely pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS796065053 |
ATF6
|
Health Risk |
Pathogenic |
Achromatopsia 7, Bilateral sensorineural hearing impairment |
| RS796065303 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS796065304 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS796065306 |
ADCY5
|
Health Risk |
Pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS796065307 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS796065308 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Inborn genetic diseases |
| RS796065309 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS796065310 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS796065311 |
MAOA
|
Health Risk |
Pathogenic |
Brunner syndrome, Brunner syndrome |
| RS796065312 |
MAOA
|
Health Risk |
Pathogenic/Likely pathogenic |
Brunner syndrome, Brunner syndrome |
| RS796065318 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS796065319 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS796065325 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS796065328 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS796065331 |
RPGR
|
Health Risk |
Likely pathogenic |
RPGR-related retinopathy, Retinal dystrophy |
| RS796065332 |
CFTR
|
Health Risk |
Pathogenic |
— |
| RS796065333 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS796065337 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS796065338 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS796065340 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS796065341 |
NOTCH1
|
Health Risk |
Pathogenic |
Early T cell progenitor acute lymphoblastic leukemia, Early T cell progenitor acute lymphoblastic leukemia |
| RS796065342 |
DNMT3A
|
Health Risk |
Pathogenic |
Early T cell progenitor acute lymphoblastic leukemia, Early T cell progenitor acute lymphoblastic leukemia |